Cytotoxic/natural killer cell cutaneous lymphomas
Marco Santucci(University of Florence), Emilio Berti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), R. Russell‐Jones(St Thomas' Hospital), Nicola Pimpinelli(University of Florence), Christian Sander(Leipzig University), Daniela Massi(University of Florence), Marco Paulli(University of Milan), Christian Hallermann(University of Göttingen), Marshall E. Kadin(University of Minnesota), Werner Kempf(University Hospital of Zurich), Chris J.L.M. Meijer(Dutch Cancer Society), Sergio Chimenti(University of Rome Tor Vergata), Rein Willemze(Leiden University Medical Center), Janine Wechsler(Hôpitaux Universitaires Henri-Mondor), Alfred C. Feller(University of Lübeck), Heike Audring(Humboldt-Universität zu Berlin), Lorenzo Cerroni(Medical University of Graz), Maria Grazia Bernengo(University of Turin), Andreas Chott(University of Vienna), Hans Konrad Müller‐Hermelink(University of Würzburg), J.L. Díaz-Pérez(Hospital de Cruces), Edgard Dippel(Franklin University), Marie‐Louise Geerts(Ghent University Hospital), Lyn M. Duncan(Massachusetts General Hospital)
Cited by 273
Related Papers
Oncogenically active MYD88 mutations in human lymphoma
|Nature|2010|1.5k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma
|The Journal of Experimental Medicine|2003|1.1k